Pharmaceuticals

Stem Cell Therapy Market Size and Growth Forecast for Businesses 2025–2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Stem Cell Therapy Market Size During 2025–2029?

The stem cell therapy market has experienced substantial expansion in recent times. It is projected to expand from $7.86 billion in 2024 to $9.26 billion in 2025, achieving a compound annual growth rate (CAGR) of 17.7%. This historical expansion can be primarily attributed to several factors, including the increasing prevalence of chronic diseases, enhanced funding from government and private organizations, swift development in emerging markets, a rise in investments in cell and gene therapies, a significant increase in healthcare expenditure, and greater pharmaceutical research and development (R&D) expenditure.

The stem cell therapy market size is expected to experience rapid growth in the next few years, projected to reach $14.6 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. This expansion during the forecast period is attributed to increasing government support, a rapid rise in the aging population, growing research and development spending, and increasing healthcare expenditure. Major trends foreseen in this period include a focus on closely monitoring advances in mesenchymal stem cell therapy to capitalize on innovations in the field. Market players are advised to collaborate with and acquire other companies to further advance product innovation and to drive revenues. Additionally, companies should consider investing in the development of iPSC-derived NK cells to treat patients. Those operating in the stem cell therapy market ought to concentrate on developing stem cell therapy, especially for cancer, to gain a competitive advantage over somatic cell competitors. Furthermore, companies in this sector should utilize artificial intelligence to improve product quality, safety, and manufacturing productivity.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3399&type=smp

What Are The Top Growth Drivers Impacting The Stem Cell Therapy Market Outlook?

The increasing occurrence of chronic illnesses has been instrumental in expanding the stem cell therapy market. Key contributors to the widespread presence of chronic diseases among individuals, thereby stimulating the need for stem cell therapy, include prolonged working hours, inadequate physical activity, and unhealthy dietary and drinking patterns. A United Nations article forecasts that by 2030, the percentage of worldwide deaths attributable to chronic diseases will rise to 70% of all fatalities. Moreover, the global burden stemming from chronic diseases is predicted to reach about 60%. Consequently, the growing frequency of chronic diseases is anticipated to accelerate the expansion of the stem cell therapy market.

What Are The Emerging Segments Gaining Attention In The Stem Cell Therapy Market?

The stem cell therapy market covered in this report is segmented –

1) By Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy

2) By Cell Source: Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells

3) By Application: Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others

4) By End-Users: Hospitals And Clinics, Research Centers, Others.

Subsegments:

1) By Allogeneic Stem Cell Therapy: Derived From Donors (Related Or Unrelated), Used For Various Conditions, Including Blood Disorders And Certain Cancers, Examples Include Umbilical Cord Blood Stem Cells And Peripheral Blood Stem Cells

2) By Autologous Stem Cell Therapy: Derived From The Patient’s Own Cells, Used For Conditions Such As Orthopedic Injuries, Cardiac Diseases, And Certain Cancers, Involves The Harvesting Of Stem Cells From Tissues Like Bone Marrow Or Adipose Tissue

What Are The Latest Industry Trends Transforming The Stem Cell Therapy Market?

Companies in the stem cell therapy market are increasingly dedicating efforts to strategic partnerships. A strategic partnership represents a mutually advantageous agreement between two companies that do not directly compete. For instance, in May 2022, SQZ Biotechnologies, a US-based biotechnology company, collaborated with STEMCELL Technologies Inc., a Canada-based biotechnology company, to create and commercialize a research-use-only (RUO) microfluidic intracellular delivery system. This system, based on SQZ’s Cell Squeeze technology, aims to provide the life sciences community with improved cell engineering capabilities for preclinical research. Both companies are set to present notable findings regarding the RUO system’s potential for efficient cargo delivery to primary immune cell types and to demonstrate advancements in cell engineering utilizing mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Who Are The Prominent Global Companies Shaping The Stem Cell Therapy Market?

Major companies operating in the stem cell therapy market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd, Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd, Cordlife India Pvt. Ltd, Lifecell International Pvt. Ltd, Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Anterogen Co., Ltd, Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc, Astrazenaca, Ablbio, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mabion, Pure Biologics, Oncoarendi Therapeutics, Celon Pharma, Becton Dickinson And Company, Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd, Astrom Biosciences Inc, Invitrogen, Cytori Therapeutics Inc, Nuvasive Inc, Bristol-Myers Squibb Aldagen Inc, Caladrius Biosciences Inc, Biogen Sa, Daiichi Sankyo Co. Ltd, Gamida Cell Ltd, Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi S.A.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Which Region Currently Holds The Largest Share Of The Stem Cell Therapy Market?

North America was the largest region in the stem cell therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Stem Cell Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3399&type=smp

Browse Through More Reports Similar to the Global Stem Cell Therapy Market 2025, By The Business Research Company

3D Cell Culture Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Transplant Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795